ScienceDex / Researcher record
Wang, Zhirui
- Rock Immune, Inc. (no department on record)
- Rock Immune LLC (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #4,658
- Early Career
NIH Funding · FY2023
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
Linked awards ($M)Award-linked rank
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2021 | $400,000 | 1 | #26,386 |
| 2023 | $1,751,664 | 2 | #4,658 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20211 record
- FY2023 · selected2 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2021 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2023 award records by amount
NIH award records listing Wang, Zhirui as a PI. Multi-PI records show the full award amount for context.
- 4R42CA261547-02R42Contact PICCR4-IL2 Bispecific Immunotoxin for Targeted Therapy of Cutaneous T-Cell Lymphoma$875.8Kaward amount
- 6R42CA261547-03R42Contact PICCR4-IL2 Bispecific Immunotoxin for Targeted Therapy of Cutaneous T-Cell Lymphoma$875.8Kaward amount
Award organizations
Organizations that administered FY2023 awards listing Wang, Zhirui as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2021First NIH AwardRock Immune LLC
- 2023$500K Cumulative Funding
- 2023$1M Cumulative Funding
- 2023$2M Cumulative Funding
- 2023Entered Top 50% NationallyRanked #4658
- 2023Entered Top 25% NationallyRanked #4658
- 2023Multi-Institutional ResearchAwards at 2 institutions